Literature DB >> 16294224

Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

Charuhas V Thakar1, Kamyar Zahedi, Monica P Revelo, Zhaohui Wang, Charles E Burnham, Sharon Barone, Shannon Bevans, Alex B Lentsch, Hamid Rabb, Manoocher Soleimani.   

Abstract

Thrombospondin 1 (TSP-1) is a matricellular protein that inhibits angiogenesis and causes apoptosis in vivo and in vitro in several cancerous cells and tissues. Here we identify TSP-1 as the molecule with the highest induction level at 3 hours of IR injury in rat and mouse kidneys subjected to ischemia/reperfusion (IR) injury using the DNA microarray approach. Northern hybridizations demonstrated that TSP-1 expression was undetectable at baseline, induced at 3 and 12 hours, and returned to baseline levels at 48 hours of reperfusion. Immunocytochemical staining identified the injured proximal tubules as the predominant sites of expression of TSP-1 in IR injury and showed colocalization of TSP-1 with activated caspase-3. Addition of purified TSP-1 to normal kidney proximal tubule cells or cells subjected to ATP depletion in vitro induced injury as demonstrated by cytochrome c immunocytochemical staining and caspase-3 activity. The deleterious role of TSP-1 in ischemic kidney injury was demonstrated directly in TSP-1 null mice, which showed significant protection against IR injury-induced renal failure and tubular damage. We propose that TSP-1 is a novel regulator of ischemic damage in the kidney and may play an important role in the pathophysiology of ischemic kidney failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16294224      PMCID: PMC1283940          DOI: 10.1172/JCI25461

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Studies on the mechanisms and kinetics of apoptosis induced by microinjection of cytochrome c in rat kidney tubule epithelial cells (NRK-52E).

Authors:  S H Chang; P C Phelps; I K Berezesky; M L Ebersberger; B F Trump
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 3.  Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.

Authors:  J E Murphy-Ullrich; M Poczatek
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

Review 4.  The cell biology of thrombospondin-1.

Authors:  H Chen; M E Herndon; J Lawler
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

5.  Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.

Authors:  J E Nör; R S Mitra; M M Sutorik; D J Mooney; V P Castle; P J Polverini
Journal:  J Vasc Res       Date:  2000 May-Jun       Impact factor: 1.934

6.  Possible molecular basis for changes in potassium handling in acute renal failure.

Authors:  H Rabb; Z Wang; G Postler; M Soleimani
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 7.  The functions of thrombospondin-1 and-2.

Authors:  J Lawler
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

8.  Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.

Authors:  M Patey; B Delemer; G Bellon; L Martiny; M Pluot; B Haye
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

Review 9.  Cell biology and molecular mechanisms of injury in ischemic acute renal failure.

Authors:  A M Sheridan; J V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2000-07       Impact factor: 2.894

10.  The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.

Authors:  Silvia Goicoechea; Manuel Antonio Pallero; Paul Eggleton; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

View more
  53 in total

1.  Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.

Authors:  Gang Jee Ko; Douglas Linfert; Hye Ryoun Jang; Elizabeth Higbee; Tonya Watkins; Chris Cheadle; Manchang Liu; Lorraine Racusen; Dmitry N Grigoryev; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Effects of low-level laser irradiation on mesenchymal stem cell proliferation: a microarray analysis.

Authors:  Yi-he Wu; Jue Wang; Ding-xu Gong; Hai-yong Gu; Sheng-shou Hu; Hao Zhang
Journal:  Lasers Med Sci       Date:  2011-09-29       Impact factor: 3.161

Review 3.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 4.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

5.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 6.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

Review 7.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

Review 8.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

9.  Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Mitsuko Iguchi; Yoshihiko Kakinuma; Atsushi Kurabayashi; Takayuki Sato; Taro Shuin; Seung-Beom Hong; Laura S Schmidt; Mutsuo Furihata
Journal:  Nephron Exp Nephrol       Date:  2008-10-27

10.  Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.

Authors:  Yiqing Guo; Jesse Pace; Zhengzhe Li; Avi Ma'ayan; Zichen Wang; Monica P Revelo; Edward Chen; Xiangchen Gu; Ahmed Attalah; Yaqi Yang; Chelsea Estrada; Vincent W Yang; John C He; Sandeep K Mallipattu
Journal:  J Am Soc Nephrol       Date:  2018-08-24       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.